Therapeutics Thursday (SCSS): HPV Vaccination: Changing Landscapes and New Challenges
Human Papillomavirus (HPV) is a common sexually transmitted infection and has been a public health target in the United States for some time. As many as 80%-90% of sexually active adults have contracted HPV and about 50% of infections are at high risk of leading to cancer. Despite the availability of commercial vaccinations for HPV, education of clinicians and patients alike remains less than optimal. Join us for a discussion on the current state of HPV vaccination in the United States and how pharmacists play a critical role.
The information presented during the podcast reflects solely the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.